A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime

Conditions

Other Hematopoietic | Pediatrics

Phase I-II

What is the purpose of this trial?

The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient for engraftment of donor hematopoietic cells. It is also to determine major toxicities from these conditioning regimens, within the first 100 days after transplantation.

  • Trial with
    Washington University School of Medicine
  • Start Date
    06/21/2018
  • End Date
    12/30/2018

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8348

Trial Image

For more information about this study, contact:

Linda Eford

  • Last Updated
    09/25/2018
  • Study HIC
    #2000021396